|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.9 CNY | -0.38% |
|
-0.59% | -7.36% |
| 06-05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
| 05-30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
The Board of Directors of Jiangsu Hengrui Medicine Co., Ltd. has authorized a buyback plan on May 15, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.36% | 36.72B | |
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
JIANGSU HENGRUI MEDICINE CO., LTD. 
